L3VLUP
ProSign in

CAI · ELV in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

CAIELV
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • CAI
  • ELV
010203040202120222023202420252026
Holders and value by quarter
QuarterCAIELV
Q3 2020none listed holders, n.a.30 holders, $15.0bn
Q4 2020none listed holders, n.a.29 holders, $16.7bn
Q1 2021none listed holders, n.a.25 holders, $18.6bn
Q2 2021none listed holders, n.a.30 holders, $19.4bn
Q3 2021none listed holders, n.a.26 holders, $18.5bn
Q4 2021none listed holders, n.a.29 holders, $23.3bn
Q1 2022none listed holders, n.a.31 holders, $23.9bn
Q2 2022none listed holders, n.a.32 holders, $23.3bn
Q3 2022none listed holders, n.a.34 holders, $22.6bn
Q4 2022none listed holders, n.a.34 holders, $25.5bn
Q1 2023none listed holders, n.a.39 holders, $22.5bn
Q2 2023none listed holders, n.a.38 holders, $20.6bn
Q3 2023none listed holders, n.a.34 holders, $19.8bn
Q4 2023none listed holders, n.a.36 holders, $20.3bn
Q1 2024none listed holders, n.a.35 holders, $21.3bn
Q2 2024none listed holders, n.a.33 holders, $22.1bn
Q3 2024none listed holders, n.a.30 holders, $20.2bn
Q4 2024none listed holders, n.a.32 holders, $15.9bn
Q1 2025none listed holders, n.a.28 holders, $17.1bn
Q2 202512 holders, $783m27 holders, $14.8bn
Q3 20259 holders, $788m27 holders, $12.7bn
Q4 202511 holders, $607m25 holders, $17.0bn
Q1 20265 holders, $804m26 holders, $13.6bn
Q2 20265 holders, $253m28 holders, $17.7bn
CAI

Caris Life Sciences Inc

Holders
0
Reported value
$0
Buyers
n.a.
Sellers
n.a.

No cross-section for this quarter.

Health care services and research
ELV

Elevance Health Inc Formerly

Holders
32
Reported value
$15.9bn
Buyers
20
Sellers
12

Breadth +8 among 94 comparable managers.

Health care services and researchManaged care

Who holds both, Q4 2024

Among the 32 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Both (0)

No tracked manager lists every one of them.

Only CAI (0)

None.

Only ELV (32)

AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Brevan Howard Capital Management LP, Bridgewater Associates LP, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Harris Associates LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, MFS Investment Management, Millennium Management LLC, Moore Capital Management LP, Neuberger Berman Group LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Ruane Cunniff & Goldfarb LP, Squarepoint Ops LLC, and 7 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →